Description
The CSO Retimax is an advanced ocular electrophysiology system developed to provide objective functional evaluation of the visual system in accordance with international ISCEV standards. It enables clinicians to assess retinal function, optic nerve pathways, and cortical responses through a comprehensive suite of electrophysiological tests.
The platform supports a wide range of diagnostic procedures, including electroretinography (ERG), pattern ERG (PERG), visual evoked potentials (VEP), electro-oculography (EOG), and multifocal testing. These modalities allow detailed analysis of retinal ganglion cells and visual pathways, facilitating early detection of glaucoma, macular degeneration, and inherited retinal disorders before structural damage becomes visible.
Retimax 2 incorporates an age-related normative database for fast, reliable comparisons and clinical decision-making. Its portable Ganzfeld stimulator and flexible testing configurations make it suitable for pediatric patients and individuals with limited cooperation, while multifocal testing enables localized functional mapping of retinal regions for precise diagnosis and monitoring.
With its combination of clinical precision, ease of use, and research-grade capabilities, Retimax 2 is a powerful solution for modern ophthalmology practices seeking comprehensive functional vision assessment.
